• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Vertex Pharmaceuticals (VRTX) Tops Q3 Earnings and Revenue Estimates

cafead

Administrator
Staff member
  • cafead   Oct 30, 2020 at 10:12: AM
via Vertex Pharmaceuticals (VRTX) came out with quarterly earnings of $2.64 per share, beating the Zacks Consensus Estimate of $2.39 per share. This compares to earnings of $1.23 per share a year ago. These figures are adjusted for non-recurring items.

article source
 

<